Featured Slider

New EAN Education Committee Chair, Irena Retorova, introduces herself with an overview of recent and upcoming EAN educational initiatives.

This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease.

Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic.

The new EAN President-Elect highlights some hopes and objectives for the future of the EAN, including updates on the work of the Covid-19 Task Force and the Coordinating Panel on Diversity, Equity and Inclusion in Neurology.

Our research paper of the month presents the results of the ‘SWIFT direct’ trial, a randomised, open-label, blinded-outcome trial, aiming to investigate whether thrombectomy alone would be non-inferior to thrombectomy plus intravenous alteplase in patients with acute ischaemic stroke due to anterior circulation large vessel occlusion.

On the final day of EAN 2022, the EAN presidency was handed over to the new president, Prof. Paul Boon, chairman and senior full professor of neurology at Ghent University Hospital and Director of 4Brain at Ghent University.

Our research paper of the month is a meta-analysis investigating the influence of intraventricular fibrinolysis on functional outcomes in patients with intracerebral haemorrhage.

Our authors of the month conducted this study in which COVID-19 patients with neurological symptoms and cognitive impairments, underwent DMI in the subacute stage of the disease.

Following a wait of three years, EAN President, Prof. Claudio Bassetti, was finally able to welcome the neurology community to a face-to-face EAN Annual Congress at the EAN 2022 Opening Session on Saturday evening.

EAN Programme Committe Chair, Tony Marson provides a preview of our forthcoming 8th annual congress.

In this population-based study, the authors aimed to investigate whether increased life expectancy determined by the adherence to a healthy lifestyle has an impact on the overall years lived with AD across the lifespan.

To evaluate the association of COVID-19 infection with olfactory bulb, our authors of the month conducted this multicenter postmortem cohort study, using ultrastructural and histopathological analysis.

EAN Scientific Committee Chair, Prof. Thomas Berger, calls for members to join EAN's Scientific & Coordinating Panels, and provides an update on recent scientific activities.

Our authors of the month evaluated an experimental treatment for human prion disease, based on a fully humanised monoclonal antibody (PRN100) addressed against the cellular prion protein (PrP).

Our authors of the month conducted this retrospective case-control study in order to investigate the association of AD with the risk of COVID-19 infection (adjusted for comorbidities and sociodemographic factors).